Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT CJS)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Opioid Use Disorder
-
Age: Between 18 Year(s) - 65 Year(s)
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Adult volunteer able to provide written informed consent in English
- Current CJS incarceration (residing in a controlled environment) with pending release date (within 6 months of randomization) OR community CJS-involvement defined as:
- Current CJS incarceration (residing in a controlled environment) with pending release date (within 6 months of anticipated randomization)
- ommunity-dwelling volunteers with current CJS-involvement. Current CJS-involvement is defined as either 1) release from any CJS incarceration or detention, or 2) under community supervision
- Current or history of moderate-to-severe opioid use disorder
- Not planning to move out of state or to new location within 6-months post-release
- Willing to accept either XR-B or XR-NTX assignment
You may not be eligible for this study if the following are true:
-
- Medical or psychiatric disorders
- Pregnant, planning conception or breast-feeding
- Allergy, hypersensitivity or medical contraindication to either medication
- Chronic pain requiring opioid pain management
- On daily stable methadone or buprenorphine (SL-B) maintenance every day for past 30 days prior to incarceration or monthly XR-NTX or XR-BUP 30 days or longer prior to incarceration AND intending to remain on same form of methadone or buprenorphine or XR-NTX maintenance upon return to the community
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.